For many years, the firm has been representing companies in the life sciences fields, including pharmaceutical companies and medical device companies, technology incubators and research centers. The attorneys who specialize in this field have accumulated extensive experience, which includes a deep understanding of the unique requirements of the companies operating in this field, and relations with the relevant regulatory entities and investors in the field. The legal teams advise clients on a wide array of aspects, including the establishment of companies, capital raising and financing transactions; and represent clients in an array of regulatory issues and issues regarding the commercialization of intellectual property.
The firm possesses significant expertise regarding transactions involving intellectual property licensing in the life sciences fields, including joint development agreements, production agreements, clinical trial agreements, and technology purchase agreements with companies and with the commercialized academic institutions. The firm represents clients in all stages of their activities, from startup companies to multinational companies.
In addition, the firm represents its Israeli and international clients in licensing proceedings before government ministries and regulatory entities, including the Ministry of Health.
"Top-notch life sciences firm in Israel, strong in medtech and biotech and with an international reach."
The Legal 500 | 2020
"Houses a multi-disciplinary practice, which handles a mix of transactional, regulatory and contentious matters for an impressive roster of major Israeli and global names."
The Legal 500 | 2020
"Goldfarb Seligman & Co.’s healthcare and life sciences team advises domestic and international biotech and pharmaceutical companies on complex commercial agreements and strategic financing and M&A transactions."
The Legal 500 | 2018
"Acts on behalf of blue-chip clients in the technology, life sciences and pharmaceutical sectors."
Chambers & Partners | 2017
"Goldfarb Seligman & Co.’s multidisciplinary team demonstrates good industry knowledge, and mainly represents pharmaceuticals and medical device companies."
The Legal 500 | 2017
Start Up Your Insurance - Life Sciences
24 November, 2020
Start-ups in the life sciences field are exposed to various risks throughout their growth, risks that can be mitigated through […]
IBA Healthcare and Life Sciences Webinar
29 September, 2020
Adv. Sharon Gazit, Head of our Corporate and Technology Department and Co-Chair of the Healthcare and Life Sciences Law Committee […]
IBA Annual Conference, 2019
23 September, 2019
Adv. Sharon Gazit, Head of our Corporate and Technology Department and Senior Vice Chair of the Healthcare and Life Sciences […]